OBERWEIS ASSET MANAGEMENT INC/ - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 364 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
OBERWEIS ASSET MANAGEMENT INC/ ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,929,100
-69.2%
50,500
-69.2%
0.20%
-78.9%
Q1 2023$6,264,688
-23.2%
164,040
+14.4%
0.97%
-43.9%
Q4 2022$8,158,891
+77.1%
143,390
+23.0%
1.73%
+60.9%
Q3 2022$4,608,000
+1.6%
116,540
+13.1%
1.08%
-6.0%
Q2 2022$4,534,000
+5.8%
103,050
-4.1%
1.15%
+33.7%
Q1 2022$4,285,000
+0.9%
107,450
+1.7%
0.86%
+10.7%
Q4 2021$4,248,000
+49.2%
105,650
+51.0%
0.78%
+31.4%
Q3 2021$2,847,000
-9.4%
69,980
+1.1%
0.59%
-14.2%
Q2 2021$3,142,000
+9.4%
69,200
+0.4%
0.69%
+17.2%
Q1 2021$2,872,00068,9000.59%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders